S
Sanarus Medical
Minimally invasive Visica Breast Therapy - Sanarus
About Sanarus Medical
Sanarus Technologies specializes in providing minimally invasive cryoablation treatments for breast cancer. The company operates in the healthcare sector, specifically targeting patients diagnosed with early-stage breast cancer. Sanarus Technologies offers a non-surgical alternative to traditional lumpectomy procedures by using extremely cold temperatures to freeze and destroy tumors and diseased tissue, thereby preventing regrowth. This innovative approach is available at participating breast centers nationwide. The business model revolves around selling its cryoablation systems and related services to healthcare providers, generating revenue through equipment sales and ongoing service contracts. The company has garnered industry recognition, including being a finalist for the 2018 Medical Marketing Media MM&M Awards for Clinical Development Marketing.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES EOther financing | Feb 2007 | $15M | $60M | Undisclosed | — |
| SERIES DOther financing | Apr 2005 | $23M | $92M | Undisclosed | — |
Growth signals
Latest recorded traffic for Sanarus Medical is 310 monthly website visits, up 210% over the last three months. Sanarus Medical's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Sanarus Medical in the Pleasanton ecosystem
The Sanarus Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
U.S. Venture Partners- FVForward Ventures
Series B and later1 investor entered at this stage
Alta Partners
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Sanarus Medical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Sanarus Medical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.








